CPC A61K 38/1729 (2013.01) [A61K 8/14 (2013.01); A61K 8/442 (2013.01); A61K 8/553 (2013.01); A61K 8/64 (2013.01); A61K 8/65 (2013.01); A61K 9/0014 (2013.01); A61K 31/198 (2013.01); A61K 31/66 (2013.01); A61K 38/1808 (2013.01); A61K 38/1825 (2013.01); A61K 38/38 (2013.01); A61K 38/39 (2013.01); A61K 45/06 (2013.01); A61M 37/0015 (2013.01); A61M 37/0092 (2013.01); A61N 5/062 (2013.01); A61Q 19/02 (2013.01); A61K 2800/91 (2013.01); A61M 2037/0007 (2013.01); A61M 2037/0023 (2013.01); A61M 2037/0061 (2013.01); A61N 5/067 (2021.08)] | 12 Claims |
1. A kit for treating an extant melasma lesion, comprising:
a mask comprising a cosmetically acceptable carrier;
a cream comprising a cosmetically acceptable carrier in combinations with a first defensin in a sub-antimicrobial concentration of the first defensin that is effective to reduce pigmentation of the extant melasma lesion on application to the extant melasma lesion as a cream formulation; and
a serum comprising a cosmetically acceptable carrier in combination with a first defensin in a sub-antimicrobial concentration of the first defensin that is effective to reduce pigmentation of the extant melasma lesion on application to the extant melasma lesion as a serum formulation.
|